Allergan (AGN) to Acquire KYTHERA Biopharma (KYTH) in ~$2.1B Deal
Tweet Send to a Friend
Allergan (NYSE: AGN) and KYTHERA Biopharmaceuticals, Inc. (Nasdaq: KYTH), a biopharmaceutical company focused on the discovery, development and commercialization of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE